COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
In the light of ONTARGET and TRANSCEND studies results, it would be interesting to
investigate the real-life telmisartan treatment tolerability. It is well known and accepted
that the Real-life setting is much more adequate to reflect the antihypertensive and safety
properties of the drug in comparison to the organized and scheduled setting of the clinical
trial. Because there are not much data on the cough in relation to telmisartan, therefore it
would we worth to observe the cough frequency and general treatment tolerance in patients
treated with telmisartan, who had to stop their previous ACE-I treatment due to cough.